Concepedia

Author

Mats Rudling

Karolinska InstitutetORCID

Also Known As

M Rudling, M. Rudling, M.A.T.S. Rudling, Mats RUDLING, Mats Rudling, Rudling, Mats

67

Publications

3.8K

Citations

26

H-Index

31

Concepts

All Affiliations

Karolinska InstitutetKarolinska University HospitalUniversity of GothenburgInsermStockholm University
MR

About

Mats Rudling is an author at Karolinska Institutet specializing in medicine, metabolism, and oxidative stress.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

11

11

720

2

Biochemistry

6

6

163

3

Health Sciences

5

5

141

4

Natural Sciences

1

1

11

5

Diabetes

1

1

28

Mats Rudling

×

32

Publications

3.5K

Citations

24

H-Index

YearCitations

PPARα is a key regulator of hepatic FGF21

Thomas Lundåsen, Mary C. Hunt, Lisa-Mari Nilsson,

Biochemical and Biophysical Research Communications

2007

373

Depletion of FOXP3+ regulatory T cells promotes hypercholesterolemia and atherosclerosis

Roland Klingenberg, Norbert Gerdes, Robert M. Badeau,

Journal of Clinical Investigation

2013

362

Hepatic cholesterol metabolism and resistance to dietary cholesterol in LXRβ-deficient mice

Siegfried Alberti, G Schuster, Paolo Parini,

Journal of Clinical Investigation

2001

361

CD1d-dependent Activation of NKT Cells Aggravates Atherosclerosis

Emmanuel Tupin, Antonino Nicoletti, Rima Elhage,

The Journal of Experimental Medicine

2004

326

Interleukin-10 Deficiency Increases Atherosclerosis, Thrombosis, and Low-density Lipoproteins in Apolipoprotein E Knockout Mice

Giuseppina Caligiuri, Mats Rudling, Véronique Ollivier,

Molecular Medicine

2003

326

Influence of Pravastatin, a Specific Inhibitor of HMG-CoA Reductase, on Hepatic Metabolism of Cholesterol

Eva Reihnér, Mats Rudling, Dagny Ståhlberg,

New England Journal of Medicine

1990

277

Increased colonic bile acid exposure: a relevant factor for symptoms and treatment in IBS

Antal Bajor, Hans Törnblom, Mats Rudling,

Gut

2014

200

Monitoring hepatic cholesterol 7α-hydroxylase activity by assay of the stable bile acid intermediate 7α-hydroxy-4-cholesten-3-one in peripheral blood

Cecilia Gälman, Ingela Arvidsson, Bo Angelin,

Journal of Lipid Research

2003

196

Randomised clinical trial: the ileal bile acid transporter inhibitor A3309 vs. placebo in patients with chronic idiopathic constipation - a double-blind study

Magnus Simrén, Antal Bajor, P.-G. Gillberg,

Alimentary Pharmacology & Therapeutics

2011

111

Ablation of the very‐long‐chain fatty acid elongase ELOVL3 in mice leads to constrained lipid storage and resistance to diet‐induced obesity

Damir Zach‐Avec, Annelie Brolinson, Rachel M. Fisher,

The FASEB Journal

2010

108

Page 1